Structured evidence table for Ashwagandha Cortisol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Ashwagandha Cortisol Randomized Trial | There is a paucity of evidence assessing the efficacy and safety of low-dose formulations of Ashwagandha in stress management. | 2 | Thanawala Shefali (2026) | Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial |
| Ashwagandha Cortisol Randomized Trial | We evaluated the efficacy and safety of AshwaSR capsules at doses of 150 and 300 mg in reducing stress and associated symptoms in healthy adults experiencing stress, over a period of 60 days of administration. | 2 | Thanawala Shefali (2026) | Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial |
| Ashwagandha Cortisol Randomized Trial | Items were designed to determine how unpredictable, uncontrollable, and overloaded subjects found their lives, with response scores ranging between 0 and 40 (scores 0–13, low; 14–26, moderate; 27–40, high perceived stress). | 2 | Thanawala Shefali (2026) | Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial |
| Ashwagandha Cortisol Randomized Trial | 1 2 [,] 3 4 [,] 5 [] Stress is a normal response to difficult situations in an individual’s life; however, prolonged and excessive mental or physical stress can be detrimental. | 2 | Thanawala Shefali (2026) | Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial |
| Ashwagandha Cortisol Randomized Trial | Aim of the study This narrative review aims to evaluate the current evidence regarding the usefulness of Withania somnifera in aiding women's hormonal balance, with a particular focus on its potential applications in PCOS and PMS. | 4 | Namysł M (2026) | Withania somnifera in Women's Hormonal Modulation: A Narrative Review With Implications for Polycystic Ovary Syndrome and Premenstrual Syndrome. |
| Ashwagandha Cortisol Randomized Trial | In PMS, ashwagandha's neuropsychiatric properties, most likely associated with GABAergic signaling and HPA modulation, may be beneficial in lowering fatigue, anxiety, and stress reactivity. | 4 | Namysł M (2026) | Withania somnifera in Women's Hormonal Modulation: A Narrative Review With Implications for Polycystic Ovary Syndrome and Premenstrual Syndrome. |
| Ashwagandha Cortisol Randomized Trial | However, as current evidence relies heavily on preclinical models and extrapolation from other populations, further large-scale, randomized clinical trials using standardized extracts are necessary to establish definitive therapeutic protocols and confirm its clinical efficacy and safety. | 4 | Namysł M (2026) | Withania somnifera in Women's Hormonal Modulation: A Narrative Review With Implications for Polycystic Ovary Syndrome and Premenstrual Syndrome. |
| Ashwagandha Cortisol Randomized Trial | Background Polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS) are among the most common hormonal diseases affecting women worldwide. | 4 | Namysł M (2026) | Withania somnifera in Women's Hormonal Modulation: A Narrative Review With Implications for Polycystic Ovary Syndrome and Premenstrual Syndrome. |
Source documents